- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CLR: CHOLESTEROL(Non-covalent)
CLR.5: 9 residues within 4Å:- Chain A: T.1024, V.1027, Q.1028, Y.1031
- Chain B: W.1060, P.1063, L.1064
- Ligands: POV.8, POV.10
7 PLIP interactions:4 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:W.1060, B:P.1063, B:P.1063, B:L.1064, A:V.1027, A:Y.1031, A:Y.1031
CLR.25: 9 residues within 4Å:- Chain B: T.1024, V.1027, Q.1028, Y.1031
- Chain C: W.1060, P.1063, L.1064
- Ligands: POV.28, POV.30
7 PLIP interactions:3 interactions with chain B, 4 interactions with chain C- Hydrophobic interactions: B:V.1027, B:Y.1031, B:Y.1031, C:W.1060, C:P.1063, C:P.1063, C:L.1064
CLR.41: 9 residues within 4Å:- Chain C: T.1024, V.1027, Q.1028, Y.1031
- Chain D: W.1060, P.1063, L.1064
- Ligands: POV.44, POV.46
7 PLIP interactions:4 interactions with chain D, 3 interactions with chain C- Hydrophobic interactions: D:W.1060, D:P.1063, D:P.1063, D:L.1064, C:V.1027, C:Y.1031, C:Y.1031
CLR.61: 9 residues within 4Å:- Chain A: W.1060, P.1063, L.1064
- Chain D: T.1024, V.1027, Q.1028, Y.1031
- Ligands: POV.64, POV.66
7 PLIP interactions:3 interactions with chain D, 4 interactions with chain A- Hydrophobic interactions: D:V.1027, D:Y.1031, D:Y.1031, A:W.1060, A:P.1063, A:P.1063, A:L.1064
- 56 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)(Non-functional Binders)
POV.6: 17 residues within 4Å:- Chain A: D.915, T.916, W.917, V.920, L.952, I.955, F.956, L.975, I.978, Q.979, Q.1103
- Chain B: F.995, L.1065, I.1068, F.1072
- Ligands: POV.10, POV.24
Ligand excluded by PLIPPOV.7: 17 residues within 4Å:- Chain A: M.706, T.713, R.714, W.715, F.838, F.841, V.845, V.846, L.849, I.958, S.961, I.964, F.965, V.967, N.968
- Ligands: POV.19, POV.29
Ligand excluded by PLIPPOV.8: 9 residues within 4Å:- Chain A: M.982, A.986, I.989, Y.1031
- Chain B: A.1067, V.1071
- Ligands: CLR.5, POV.9, POV.24
Ligand excluded by PLIPPOV.9: 11 residues within 4Å:- Chain A: Q.983, A.986, I.989, I.990, I.997
- Chain D: N.968, L.970, L.971
- Ligands: POV.8, POV.56, POV.63
Ligand excluded by PLIPPOV.10: 8 residues within 4Å:- Chain A: R.941, I.948, L.952, W.1020
- Chain B: D.1057, W.1060
- Ligands: CLR.5, POV.6
Ligand excluded by PLIPPOV.11: 2 residues within 4Å:- Chain A: I.930, I.942
Ligand excluded by PLIPPOV.12: 3 residues within 4Å:- Chain A: I.1023
- Ligands: POV.13, POV.57
Ligand excluded by PLIPPOV.13: 3 residues within 4Å:- Chain A: N.1018, W.1020
- Ligands: POV.12
Ligand excluded by PLIPPOV.14: 1 residues within 4Å:- Chain A: F.937
Ligand excluded by PLIPPOV.19: 9 residues within 4Å:- Chain A: R.714, W.715, F.853, V.967, N.968, R.969
- Ligands: POV.7, POV.20, POV.29
Ligand excluded by PLIPPOV.20: 10 residues within 4Å:- Chain A: F.853, A.856, Y.857, F.861
- Chain B: T.1019, V.1026, V.1027
- Ligands: POV.19, POV.21, POV.32
Ligand excluded by PLIPPOV.21: 3 residues within 4Å:- Chain A: Y.857
- Ligands: POV.20, POV.22
Ligand excluded by PLIPPOV.22: 1 residues within 4Å:- Ligands: POV.21
Ligand excluded by PLIPPOV.23: 3 residues within 4Å:- Chain D: M.982
- Ligands: POV.62, POV.64
Ligand excluded by PLIPPOV.24: 3 residues within 4Å:- Chain A: M.982
- Ligands: POV.6, POV.8
Ligand excluded by PLIPPOV.26: 17 residues within 4Å:- Chain B: D.915, T.916, W.917, V.920, L.952, I.955, F.956, L.975, I.978, Q.979, Q.1103
- Chain C: F.995, L.1065, I.1068, F.1072
- Ligands: POV.30, POV.40
Ligand excluded by PLIPPOV.27: 17 residues within 4Å:- Chain B: M.706, T.713, R.714, W.715, F.838, F.841, V.845, V.846, L.849, I.958, S.961, I.964, F.965, V.967, N.968
- Ligands: POV.36, POV.45
Ligand excluded by PLIPPOV.28: 9 residues within 4Å:- Chain B: M.982, A.986, I.989, Y.1031
- Chain C: A.1067, V.1071
- Ligands: CLR.25, POV.29, POV.40
Ligand excluded by PLIPPOV.29: 11 residues within 4Å:- Chain A: N.968, L.970, L.971
- Chain B: Q.983, A.986, I.989, I.990, I.997
- Ligands: POV.7, POV.19, POV.28
Ligand excluded by PLIPPOV.30: 8 residues within 4Å:- Chain B: R.941, I.948, L.952, W.1020
- Chain C: D.1057, W.1060
- Ligands: CLR.25, POV.26
Ligand excluded by PLIPPOV.31: 2 residues within 4Å:- Chain B: I.930, I.942
Ligand excluded by PLIPPOV.32: 3 residues within 4Å:- Chain B: I.1023
- Ligands: POV.20, POV.33
Ligand excluded by PLIPPOV.33: 3 residues within 4Å:- Chain B: N.1018, W.1020
- Ligands: POV.32
Ligand excluded by PLIPPOV.34: 1 residues within 4Å:- Chain B: F.937
Ligand excluded by PLIPPOV.36: 9 residues within 4Å:- Chain B: R.714, W.715, F.853, V.967, N.968, R.969
- Ligands: POV.27, POV.37, POV.45
Ligand excluded by PLIPPOV.37: 10 residues within 4Å:- Chain B: F.853, A.856, Y.857, F.861
- Chain C: T.1019, V.1026, V.1027
- Ligands: POV.36, POV.38, POV.48
Ligand excluded by PLIPPOV.38: 3 residues within 4Å:- Chain B: Y.857
- Ligands: POV.37, POV.39
Ligand excluded by PLIPPOV.39: 1 residues within 4Å:- Ligands: POV.38
Ligand excluded by PLIPPOV.40: 3 residues within 4Å:- Chain B: M.982
- Ligands: POV.26, POV.28
Ligand excluded by PLIPPOV.42: 17 residues within 4Å:- Chain C: D.915, T.916, W.917, V.920, L.952, I.955, F.956, L.975, I.978, Q.979, Q.1103
- Chain D: F.995, L.1065, I.1068, F.1072
- Ligands: POV.46, POV.60
Ligand excluded by PLIPPOV.43: 17 residues within 4Å:- Chain C: M.706, T.713, R.714, W.715, F.838, F.841, V.845, V.846, L.849, I.958, S.961, I.964, F.965, V.967, N.968
- Ligands: POV.52, POV.65
Ligand excluded by PLIPPOV.44: 9 residues within 4Å:- Chain C: M.982, A.986, I.989, Y.1031
- Chain D: A.1067, V.1071
- Ligands: CLR.41, POV.45, POV.60
Ligand excluded by PLIPPOV.45: 11 residues within 4Å:- Chain B: N.968, L.970, L.971
- Chain C: Q.983, A.986, I.989, I.990, I.997
- Ligands: POV.27, POV.36, POV.44
Ligand excluded by PLIPPOV.46: 8 residues within 4Å:- Chain C: R.941, I.948, L.952, W.1020
- Chain D: D.1057, W.1060
- Ligands: CLR.41, POV.42
Ligand excluded by PLIPPOV.47: 2 residues within 4Å:- Chain C: I.930, I.942
Ligand excluded by PLIPPOV.48: 3 residues within 4Å:- Chain C: I.1023
- Ligands: POV.37, POV.49
Ligand excluded by PLIPPOV.49: 3 residues within 4Å:- Chain C: N.1018, W.1020
- Ligands: POV.48
Ligand excluded by PLIPPOV.50: 1 residues within 4Å:- Chain C: F.937
Ligand excluded by PLIPPOV.52: 9 residues within 4Å:- Chain C: R.714, W.715, F.853, V.967, N.968, R.969
- Ligands: POV.43, POV.53, POV.65
Ligand excluded by PLIPPOV.53: 10 residues within 4Å:- Chain C: F.853, A.856, Y.857, F.861
- Chain D: T.1019, V.1026, V.1027
- Ligands: POV.52, POV.54, POV.68
Ligand excluded by PLIPPOV.54: 3 residues within 4Å:- Chain C: Y.857
- Ligands: POV.53, POV.55
Ligand excluded by PLIPPOV.55: 1 residues within 4Å:- Ligands: POV.54
Ligand excluded by PLIPPOV.56: 9 residues within 4Å:- Chain D: R.714, W.715, F.853, V.967, N.968, R.969
- Ligands: POV.9, POV.57, POV.63
Ligand excluded by PLIPPOV.57: 10 residues within 4Å:- Chain A: T.1019, V.1026, V.1027
- Chain D: F.853, A.856, Y.857, F.861
- Ligands: POV.12, POV.56, POV.58
Ligand excluded by PLIPPOV.58: 3 residues within 4Å:- Chain D: Y.857
- Ligands: POV.57, POV.59
Ligand excluded by PLIPPOV.59: 1 residues within 4Å:- Ligands: POV.58
Ligand excluded by PLIPPOV.60: 3 residues within 4Å:- Chain C: M.982
- Ligands: POV.42, POV.44
Ligand excluded by PLIPPOV.62: 17 residues within 4Å:- Chain A: F.995, L.1065, I.1068, F.1072
- Chain D: D.915, T.916, W.917, V.920, L.952, I.955, F.956, L.975, I.978, Q.979, Q.1103
- Ligands: POV.23, POV.66
Ligand excluded by PLIPPOV.63: 17 residues within 4Å:- Chain D: M.706, T.713, R.714, W.715, F.838, F.841, V.845, V.846, L.849, I.958, S.961, I.964, F.965, V.967, N.968
- Ligands: POV.9, POV.56
Ligand excluded by PLIPPOV.64: 9 residues within 4Å:- Chain A: A.1067, V.1071
- Chain D: M.982, A.986, I.989, Y.1031
- Ligands: POV.23, CLR.61, POV.65
Ligand excluded by PLIPPOV.65: 11 residues within 4Å:- Chain C: N.968, L.970, L.971
- Chain D: Q.983, A.986, I.989, I.990, I.997
- Ligands: POV.43, POV.52, POV.64
Ligand excluded by PLIPPOV.66: 8 residues within 4Å:- Chain A: D.1057, W.1060
- Chain D: R.941, I.948, L.952, W.1020
- Ligands: CLR.61, POV.62
Ligand excluded by PLIPPOV.67: 2 residues within 4Å:- Chain D: I.930, I.942
Ligand excluded by PLIPPOV.68: 3 residues within 4Å:- Chain D: I.1023
- Ligands: POV.53, POV.69
Ligand excluded by PLIPPOV.69: 3 residues within 4Å:- Chain D: N.1018, W.1020
- Ligands: POV.68
Ligand excluded by PLIPPOV.70: 1 residues within 4Å:- Chain D: F.937
Ligand excluded by PLIP- 4 x CA: CALCIUM ION(Non-covalent)
CA.15: 5 residues within 4Å:- Chain A: E.893, Q.896, N.918, D.921, R.960
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:E.893, A:E.893, A:D.921
CA.35: 5 residues within 4Å:- Chain B: E.893, Q.896, N.918, D.921, R.960
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:E.893, B:E.893, B:D.921
CA.51: 5 residues within 4Å:- Chain C: E.893, Q.896, N.918, D.921, R.960
3 PLIP interactions:3 interactions with chain C- Metal complexes: C:E.893, C:E.893, C:D.921
CA.71: 5 residues within 4Å:- Chain D: E.893, Q.896, N.918, D.921, R.960
3 PLIP interactions:3 interactions with chain D- Metal complexes: D:E.893, D:E.893, D:D.921
- 3 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Z. et al., Structure of a TRPM2 channel in complex with Ca2+explains unique gating regulation. Elife (2018)
- Release Date
- 2018-05-16
- Peptides
- Predicted protein: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CLR: CHOLESTEROL(Non-covalent)
- 56 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)(Non-functional Binders)
- 4 x CA: CALCIUM ION(Non-covalent)
- 3 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Z. et al., Structure of a TRPM2 channel in complex with Ca2+explains unique gating regulation. Elife (2018)
- Release Date
- 2018-05-16
- Peptides
- Predicted protein: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.